ARCHIVES

Guest Editorial: The Walue of Quality of Life Data In Judging Patient Benefit: experts Respond To ODAC

This article is from The Cancer Letter archive.

Vol. 25 No. 33 | September 3, 1999

Download PDF Visit The Full Archive

Related Articles

Advisors approve set-aside for alternative medicine “best case series.”

November 19, 2004

NTP Release Third Report On Carcinogens

January 13, 1984

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

May 9, 2003

CREG Announced for Premorbid Psychological Factors Study

August 27, 1976

Research Opportunities On Diet, Nutrition Outlined To NCAB

July 11, 1975

Propac To Recommend Reclassification Of Five Leukemia/Lymphoma Diagnosis Related Groups

March 21, 1986